image
Financial Services - Banks - Regional - NASDAQ - US
$ 15.24
3.04 %
$ 752 M
Market Cap
10.51
P/E
1. INTRINSIC VALUE

This DCF valuation model was last updated on Jan, 18, 2025.

The intrinsic value of one CFB stock under the worst case scenario is HIDDEN Compared to the current market price of 15.2 USD, CrossFirst Bankshares, Inc. is HIDDEN

This DCF valuation model was last updated on Jan, 18, 2025.

The intrinsic value of one CFB stock under the base case scenario is HIDDEN Compared to the current market price of 15.2 USD, CrossFirst Bankshares, Inc. is HIDDEN

This DCF valuation model was last updated on Jan, 18, 2025.

The intrinsic value of one CFB stock under the best case scenario is HIDDEN Compared to the current market price of 15.2 USD, CrossFirst Bankshares, Inc. is HIDDEN

2. FUNDAMENTAL ANALYSIS
FINANCIALS
231 M REVENUE
299920.78%
84.1 M OPERATING INCOME
-36.55%
66.7 M NET INCOME
8.23%
99.4 M OPERATING CASH FLOW
23.65%
-658 M INVESTING CASH FLOW
-6.18%
514 M FINANCING CASH FLOW
43.97%
67.1 M REVENUE
-47.84%
25 M OPERATING INCOME
-4.87%
19.6 M NET INCOME
5.51%
31.7 M OPERATING CASH FLOW
51.08%
54.4 M INVESTING CASH FLOW
145.68%
-99.5 M FINANCING CASH FLOW
-70.31%
Balance Sheet CrossFirst Bankshares, Inc.
image
Current Assets 234 M
Cash & Short-Term Investments 234 M
Receivables 0
Other Current Assets 0
Non-Current Assets 7.15 B
Long-Term Investments 11.9 M
PP&E 101 M
Other Non-Current Assets 7.03 B
Current Liabilities 2.66 B
Accounts Payable 94.4 M
Short-Term Debt 0
Other Current Liabilities 2.57 B
Non-Current Liabilities 6.65 B
Long-Term Debt 86.8 M
Other Non-Current Liabilities 6.57 B
EFFICIENCY
Earnings Waterfall CrossFirst Bankshares, Inc.
image
Revenue 231 M
Cost Of Revenue 0
Gross Profit 231 M
Operating Expenses 245 M
Operating Income 84.1 M
Other Expenses 17.4 M
Net Income 66.7 M
RATIOS
100.00% GROSS MARGIN
100.00%
36.41% OPERATING MARGIN
36.41%
28.86% NET MARGIN
28.86%
9.41% ROE
9.41%
0.90% ROA
0.90%
8.39% ROIC
8.39%
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis CrossFirst Bankshares, Inc.
image
Net Income 66.7 M
Depreciation & Amortization 9.46 M
Capital Expenditures -8.95 M
Stock-Based Compensation 5.28 M
Change in Working Capital 6.2 M
Others 20 M
Free Cash Flow 90.4 M
3. WALL STREET ANALYSTS ESTIMATES
Wall Street Analysts Price Targets CrossFirst Bankshares, Inc.
image
Wall Street analysts predict an average 1-year price target for CFB of $19 , with forecasts ranging from a low of $17 to a high of $21 .
CFB Lowest Price Target Wall Street Target
17 USD 11.55%
CFB Average Price Target Wall Street Target
19 USD 24.67%
CFB Highest Price Target Wall Street Target
21 USD 37.80%
4. DIVIDEND ANALYSIS
5. COMPETITION
6. Ownership
Insider Ownership CrossFirst Bankshares, Inc.
image
Sold
0-3 MONTHS
0 USD 0
3-6 MONTHS
0 USD 0
6-9 MONTHS
0 USD 0
9-12 MONTHS
0 USD 0
Bought
100 K USD 1
0-3 MONTHS
0 USD 0
3-6 MONTHS
0 USD 0
6-9 MONTHS
0 USD 0
9-12 MONTHS
Date Value Insider Amount Avg Price
2 months ago
Oct 30, 2024
Bought 100 K USD
Bruce George
Director
+ 100
1000 USD
1 year ago
Nov 06, 2023
Sell 17.1 K USD
Hansen George E. III
Director
- 1500
11.42 USD
1 year ago
Oct 30, 2023
Sell 93.1 K USD
Robinson Michael Kent
Director
- 8889
10.47 USD
1 year ago
Oct 26, 2023
Sell 247 K USD
Robinson Michael Kent
Director
- 23948
10.31 USD
1 year ago
Oct 27, 2023
Sell 15.8 K USD
Robinson Michael Kent
Director
- 1530
10.3 USD
1 year ago
Oct 20, 2023
Sell 199 K USD
Robinson Michael Kent
Director
- 18729
10.64 USD
1 year ago
Oct 23, 2023
Sell 72.2 K USD
Robinson Michael Kent
Director
- 6904
10.46 USD
1 year ago
May 04, 2023
Bought 47.5 K USD
Kuykendall James W.
Director
+ 5000
9.5 USD
1 year ago
May 03, 2023
Bought 97.5 K USD
DALEY MICHAEL JOHN
CHIEF ACCOUNTING OFFICER
+ 10000
9.75 USD
1 year ago
Mar 10, 2023
Bought 42.8 K USD
King Mason
+ 3600
11.89 USD
3 years ago
Nov 30, 2021
Bought 14.1 K USD
Maddox Mike
+ 1000
14.07 USD
1 year ago
Feb 13, 2023
Sell 14.1 K USD
Robinson Michael Kent
- 1000
14.1 USD
1 year ago
Jan 31, 2023
Sell 13.5 K USD
Robinson Michael Kent
- 1000
13.5 USD
2 years ago
Dec 15, 2022
Sell 31.2 K USD
Bruce George
Director
- 2500
12.5 USD
2 years ago
Sep 14, 2022
Bought 32.3 K USD
Kuykendall James W.
+ 2500
12.93 USD
2 years ago
Aug 15, 2022
Sell 220 K USD
Humphreys Lance
director:
- 14122
15.61 USD
2 years ago
Jul 25, 2022
Sell 16.3 K USD
Robinson Michael Kent
director:
- 1207
13.5 USD
2 years ago
Jul 21, 2022
Bought 97.4 K USD
Clouse Benjamin R
director: CFO
+ 7500
12.99 USD
2 years ago
Jul 19, 2022
Sell 3.96 K USD
Robinson Michael Kent
director:
- 293
13.5 USD
2 years ago
Jun 22, 2022
Sell 40.5 K USD
Robinson Michael Kent
director:
- 3000
13.5 USD
2 years ago
Apr 06, 2022
Sell 23 K USD
Robinson Michael Kent
director:
- 1500
15.33 USD
2 years ago
Mar 07, 2022
Sell 23.4 K USD
Robinson Michael Kent
director:
- 1500
15.57 USD
2 years ago
Feb 07, 2022
Sell 23.9 K USD
Robinson Michael Kent
- 1500
15.94 USD
3 years ago
Jan 06, 2022
Sell 23.8 K USD
Robinson Michael Kent
- 1500
15.9 USD
3 years ago
Dec 06, 2021
Sell 22.1 K USD
Robinson Michael Kent
- 1500
14.71 USD
3 years ago
Nov 30, 2021
Bought 14.1 K USD
Maddox Mike
+ 1000
14.07 USD
3 years ago
Nov 08, 2021
Sell 22.9 K USD
Robinson Michael Kent
- 1500
15.25 USD
3 years ago
Nov 01, 2021
Bought 107 K USD
Clouse Benjamin R
+ 7400
14.49 USD
3 years ago
Oct 22, 2021
Sell 109 K USD
O'Toole David L.
- 7547
14.5 USD
3 years ago
Oct 25, 2021
Sell 25 K USD
O'Toole David L.
- 1723
14.5 USD
3 years ago
Oct 07, 2021
Sell 20.2 K USD
Robinson Michael Kent
- 1500
13.5 USD
3 years ago
Oct 05, 2021
Sell 7.02 K USD
Robinson Michael Kent
- 520
13.5 USD
3 years ago
Oct 01, 2021
Sell 13.2 K USD
Robinson Michael Kent
- 980
13.5 USD
3 years ago
Aug 06, 2021
Sell 20.6 K USD
Robinson Michael Kent
- 1500
13.72 USD
3 years ago
Jul 06, 2021
Sell 13.9 K USD
Robinson Michael Kent
Director
- 1000
13.92 USD
3 years ago
Jun 07, 2021
Sell 14.9 K USD
Robinson Michael Kent
Director
- 1000
14.94 USD
3 years ago
May 06, 2021
Sell 14.9 K USD
Robinson Michael Kent
Director
- 1000
14.9 USD
3 years ago
Apr 21, 2021
Sell 6.66 K USD
O'Toole David L.
CFO & Chief Investment Officer
- 500
13.31 USD
3 years ago
Apr 14, 2021
Sell 6.81 K USD
O'Toole David L.
CFO & Chief Investment Officer
- 500
13.62 USD
3 years ago
Apr 07, 2021
Sell 6.91 K USD
O'Toole David L.
CFO & Chief Investment Officer
- 500
13.82 USD
3 years ago
Apr 06, 2021
Sell 13.9 K USD
Robinson Michael Kent
Director
- 1000
13.91 USD
3 years ago
Apr 01, 2021
Sell 277 K USD
JONES GEORGE F JR
Director
- 20000
13.85 USD
3 years ago
Mar 31, 2021
Sell 6.99 K USD
O'Toole David L.
CFO & Chief Investment Officer
- 500
13.98 USD
3 years ago
Mar 22, 2021
Bought 99.4 K USD
Merfen Jana
Chief Technology Officer
+ 7100
14 USD
3 years ago
Mar 24, 2021
Sell 6.76 K USD
O'Toole David L.
CFO & Chief Investment Officer
- 500
13.53 USD
3 years ago
Mar 17, 2021
Sell 7.3 K USD
O'Toole David L.
CFO & Chief Investment Officer
- 500
14.6 USD
4 years ago
Jan 13, 2021
Sell 5.92 K USD
O'Toole David L.
CFO & Chief Investment Officer
- 500
11.84 USD
3 years ago
Jan 27, 2021
Sell 5.75 K USD
O'Toole David L.
CFO & Chief Investment Officer
- 500
11.5 USD
3 years ago
Feb 03, 2021
Sell 5.81 K USD
O'Toole David L.
CFO & Chief Investment Officer
- 500
11.62 USD
3 years ago
Mar 10, 2021
Sell 7.6 K USD
O'Toole David L.
CFO & Chief Investment Officer
- 500
15.21 USD
3 years ago
Mar 08, 2021
Sell 14.4 K USD
Robinson Michael Kent
Director
- 1000
14.45 USD
3 years ago
Mar 03, 2021
Sell 6.84 K USD
O'Toole David L.
CFO & Chief Investment Officer
- 500
13.68 USD
3 years ago
Feb 24, 2021
Sell 6.38 K USD
O'Toole David L.
CFO & Chief Investment Officer
- 500
12.76 USD
3 years ago
Feb 17, 2021
Sell 5.83 K USD
O'Toole David L.
CFO & Chief Investment Officer
- 500
11.66 USD
3 years ago
Feb 10, 2021
Sell 6.17 K USD
O'Toole David L.
CFO & Chief Investment Officer
- 500
12.34 USD
3 years ago
Feb 08, 2021
Sell 11.9 K USD
Robinson Michael Kent
Director
- 1000
11.94 USD
4 years ago
Jan 20, 2021
Sell 5.94 K USD
O'Toole David L.
CFO & Chief Investment Officer
- 500
11.89 USD
4 years ago
Jan 06, 2021
Sell 11.1 K USD
Robinson Michael Kent
Director
- 1000
11.06 USD
4 years ago
Nov 09, 2020
Sell 8.62 K USD
O'Toole David L.
CFO & Chief Investment Officer
- 907
9.5 USD
4 years ago
Oct 21, 2020
Sell 884 USD
O'Toole David L.
CFO & Chief Investment Officer
- 93
9.5 USD
4 years ago
Oct 14, 2020
Sell 4.86 K USD
O'Toole David L.
CFO & Chief Investment Officer
- 500
9.71 USD
4 years ago
Oct 07, 2020
Sell 4.78 K USD
O'Toole David L.
CFO & Chief Investment Officer
- 500
9.55 USD
4 years ago
Oct 05, 2020
Sell 9.5 K USD
O'Toole David L.
CFO & Chief Investment Officer
- 1000
9.5 USD
4 years ago
Sep 16, 2020
Sell 4.82 K USD
O'Toole David L.
CFO & Chief Investment Officer
- 500
9.64 USD
4 years ago
Sep 09, 2020
Sell 4.75 K USD
O'Toole David L.
CFO & Chief Investment Officer
- 500
9.5 USD
4 years ago
Sep 04, 2020
Sell 4.75 K USD
O'Toole David L.
CFO & Chief Investment Officer
- 500
9.5 USD
4 years ago
Aug 27, 2020
Sell 4.75 K USD
O'Toole David L.
CFO & Chief Investment Officer
- 500
9.5 USD
4 years ago
Aug 19, 2020
Sell 4.75 K USD
O'Toole David L.
CFO & Chief Investment Officer
- 500
9.5 USD
4 years ago
Aug 12, 2020
Sell 5.06 K USD
O'Toole David L.
CFO & Chief Investment Officer
- 500
10.11 USD
4 years ago
Aug 05, 2020
Sell 4.82 K USD
O'Toole David L.
CFO & Chief Investment Officer
- 500
9.63 USD
4 years ago
Jul 29, 2020
Sell 4.82 K USD
O'Toole David L.
CFO & Chief Investment Officer
- 500
9.64 USD
4 years ago
Jul 22, 2020
Sell 4.98 K USD
O'Toole David L.
CPO & Chief Investment Officer
- 500
9.96 USD
4 years ago
Jul 15, 2020
Sell 4.91 K USD
O'Toole David L.
CFO & Chief Investment Officer
- 500
9.82 USD
4 years ago
Jul 13, 2020
Sell 4.75 K USD
O'Toole David L.
CFO & Chief Investment Officer
- 500
9.5 USD
4 years ago
Jul 01, 2020
Sell 4.84 K USD
O'Toole David L.
CFO & Chief Investment Officer
- 500
9.68 USD
4 years ago
May 19, 2020
Bought 108 K USD
King Mason
Director
+ 12000
9.0368 USD
4 years ago
Mar 12, 2020
Bought 8 K USD
Kuykendall James W.
Director
+ 1000
8 USD
4 years ago
Mar 12, 2020
Bought 8.25 K USD
Kuykendall James W.
Director
+ 1000
8.25 USD
4 years ago
Mar 10, 2020
Bought 4.4 K USD
Kuykendall James W.
Director
+ 500
8.81 USD
4 years ago
Feb 13, 2020
Sell 40.8 K USD
Robinson Michael Kent
Director
- 3000
13.6 USD
5 years ago
May 24, 2019
Sell 119 K USD
Shadwick Jay
Director
- 7000
17 USD
5 years ago
May 21, 2019
Sell 340 K USD
Maddox Mike
Director
- 20000
17 USD
20 years ago
Sep 09, 2004
Sell 612 K USD
ZOFFINGER GEORGE R
Director
- 22200
27.55 USD
20 years ago
Sep 09, 2004
Sell 38.7 K USD
ZOFFINGER GEORGE R
Director
- 1388
27.85 USD
20 years ago
Aug 25, 2004
Sell 131 K USD
WHITESIDE JOSEPH J
Director
- 4800
27.31 USD
20 years ago
Aug 25, 2004
Sell 5.48 K USD
WHITESIDE JOSEPH J
Director
- 200
27.38 USD
20 years ago
Aug 25, 2004
Sell 11.2 K USD
WHITESIDE JOSEPH J
Director
- 411
27.28 USD
20 years ago
Aug 25, 2004
Sell 229 K USD
WHITESIDE JOSEPH J
Director
- 8400
27.25 USD
20 years ago
Aug 26, 2004
Sell 101 K USD
WHITESIDE JOSEPH J
Director
- 3700
27.25 USD
21 years ago
Nov 07, 2003
Sell 26.4 K USD
TAYLOR ROBERT D
Director
- 1000
26.35 USD
21 years ago
Nov 07, 2003
Sell 60.6 K USD
TAYLOR ROBERT D
Director
- 2300
26.33 USD
21 years ago
Nov 07, 2003
Sell 68.4 K USD
TAYLOR ROBERT D
Director
- 2600
26.29 USD
21 years ago
Nov 07, 2003
Sell 42.2 K USD
TAYLOR ROBERT D
Director
- 1600
26.35 USD
21 years ago
Nov 07, 2003
Sell 26.3 K USD
TAYLOR ROBERT D
Director
- 1000
26.31 USD
7. News
Arrowhead Pharmaceuticals Presents Interim Clinical Data on ARO-CFB for the Treatment of Complement Mediated Diseases PASADENA, Calif.--(BUSINESS WIRE)---- $arwr--Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced interim results from a Phase 1/2a clinical study of ARO-CFB, the company's investigational RNA interference (RNAi) therapeutic targeting complement factor B being developed as a potential treatment for complement mediated diseases. The data were presented today, December 11, 2024, at the 8th Complement-Based Drug Development Summit being held in Boston. “Dysregulated activation of the complement sy. businesswire.com - 1 month ago
CROSSFIRST BANKSHARES INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of CrossFirst Bankshares, Inc. - CFB NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of CrossFirst Bankshares, Inc. (NasdaqGS: CFB) to First Busey Corporation (NasdaqGS: BUSE). Under the terms of the proposed transaction, shareholders of CrossFirst will receive 0.6675 shares of First Busey common stock for each share of CrossFirst that they own. KSF is seeking to determine whether this considerat. businesswire.com - 1 month ago
CrossFirst (CFB) Upgraded to Strong Buy: What Does It Mean for the Stock? CrossFirst (CFB) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy). zacks.com - 2 months ago
Best Value Stocks to Buy for November 6th BABA, SUOPY and CFB made it to the Zacks Rank #1 (Strong Buy) value stocks list on November 6, 2024. zacks.com - 2 months ago
Best Value Stocks to Buy for October 31st MATX, HRB and CFB made it to the Zacks Rank #1 (Strong Buy) value stocks list on October 31, 2024. zacks.com - 2 months ago
Here's What Key Metrics Tell Us About CrossFirst (CFB) Q3 Earnings Although the revenue and EPS for CrossFirst (CFB) give a sense of how its business performed in the quarter ended September 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers. zacks.com - 2 months ago
CrossFirst Bankshares (CFB) Q3 Earnings and Revenues Top Estimates CrossFirst Bankshares (CFB) came out with quarterly earnings of $0.43 per share, beating the Zacks Consensus Estimate of $0.39 per share. This compares to earnings of $0.37 per share a year ago. zacks.com - 2 months ago
CrossFirst Bankshares, Inc. Reports Third Quarter 2024 Results LEAWOOD, Kan., Oct. 22, 2024 (GLOBE NEWSWIRE) -- CrossFirst Bankshares, Inc. (Nasdaq: CFB), the bank holding company for CrossFirst Bank, today reported operating results for the third quarter ended September 30, 2024. globenewswire.com - 2 months ago
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates FRZA and CFB on Behalf of Shareholders NEW YORK, NY / ACCESSWIRE / September 6, 2024 / Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: Forza X1, Inc. (NASDAQ:FRZA)'s sale to Twin Vee PowerCats Co. for 0.61166627 shares of Twin Vee common stock for each share of Forza common stock. Upon closing of the proposed transaction, Forza shareholders would own approximately 36% of the combined company. accesswire.com - 4 months ago
SHAREHOLDER INVESTIGATION: The M&A Class Action Firm Investigates the Merger of Crossfirst Bankshares, Inc. – CFB NEW YORK, Sept. 05, 2024 (GLOBE NEWSWIRE) -- Monteverde & Associates PC (the “M&A Class Action Firm”), has recovered money for shareholders and is recognized as a Top 50 Firm in the 2018-2022 ISS Securities Class Action Services Report. We are headquartered at the Empire State Building in New York City and are investigating Crossfirst Bankshares, Inc. (Nasdaq : CFB ), relating to its proposed merger with First Busey Corporation. Under the terms of the agreement, Crossfirst common stock will automatically be converted into the right to receive 0.6675 shares of Busey common stock. globenewswire.com - 4 months ago
Shareholder Alert: Ademi LLP investigates whether CrossFirst Bankshares, Inc. has obtained a Fair Price for its Public Shareholders MILWAUKEE , Sept. 5, 2024 /PRNewswire/ -- Ademi LLP is investigating CrossFirst (Nasdaq: CFB) for possible breaches of fiduciary duty and other violations of law in its transaction with Busey. prnewswire.com - 4 months ago
8. Profile Summary

CrossFirst Bankshares, Inc. CFB

image
COUNTRY US
INDUSTRY Banks - Regional
MARKET CAP $ 752 M
Dividend Yield 0.02%
Description CrossFirst Bankshares, Inc. operates as the bank holding company for CrossFirst Bank that provides various banking and financial services to businesses, business owners, professionals, and its personal networks. The company offers commercial real estate, construction and development, 1-4 family real estate, commercial, energy, and consumer loans. It also provides a range of deposit products consisting of noninterest-bearing demand and interest-bearing deposits, which include transaction accounts, savings accounts, money market accounts, and certificates of deposit; and personal and business checking and savings accounts, as well as negotiable order of withdrawal accounts; and brokered and reciprocal deposits. In addition, the company offers international banking services; treasury management services; automated teller machine access; and mobile banking services. Further, it holds investments in marketable securities. As of December 31, 2021, it had nine full-service banking offices in Kansas, Missouri, Oklahoma, Arizona, and Texas. CrossFirst Bankshares, Inc. was founded in 2007 and is headquartered in Leawood, Kansas.
Contact 11440 Tomahawk Creek Parkway, Leawood, KS, 66211 https://www.crossfirstbank.com
IPO Date Aug. 15, 2019
Employees 453
Officers Mr. Benjamin Russell Clouse CPA Chief Financial Officer Ms. Jana Merfen Chief Technology Officer Ms. Meggin Nilssen Chief Marketing Officer & Chief of Staff Mr. Steve M. Peterson Chief Banking Officer Ms. Amy J. Fauss Chief Operating Officer Mr. Michael John Daley Chief Accounting Officer Mr. Jason Dudley Market President in Frisco, Texas Mr. Michael J. Maddox President, Chief Executive Officer & Director Mr. W. Randall Rapp CPA President of CrossFirst Bank Ms. Amy C. Abrams General Counsel & Corporate Secretary